A Quantum Leap in mRNA Quantitation

Cytokines, unique growth factors that are secreted by various cells of the body, include interleukins (ILs), interferons (IFNs), and tumor necrosis factors (TNFs). These proteins bind to target cell surface receptors and activate cell proliferation and/or differentiation. Until recently, research that quantifies levels of cytokine-specific mRNA using traditional methods such as the northern blot, slot blot, quantitative RT-PCR, and ribonuclease protection assay (RPA) has been labor-intensive and

Written byHillary Sussman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Cytokines, unique growth factors that are secreted by various cells of the body, include interleukins (ILs), interferons (IFNs), and tumor necrosis factors (TNFs). These proteins bind to target cell surface receptors and activate cell proliferation and/or differentiation. Until recently, research that quantifies levels of cytokine-specific mRNA using traditional methods such as the northern blot, slot blot, quantitative RT-PCR, and ribonuclease protection assay (RPA) has been labor-intensive and time-consuming. Additionally, these methods are either unsuitable for high-throughput analyses or require the use of a radioisotope.

R&D Systems' Quantikine mRNA kit R&D Systems Inc., of Minneapolis, has developed a novel method for quantitation of cytokine-specific mRNA using a colorimetric microplate assay. Total or poly-(A)+ RNA samples are first hybridized with gene-specific biotin-labeled oligonucleotide probes and digoxigenin-labeled detection probes. The RNA/probe hybrid then is captured on transfer to a streptavidin-coated microplate, and color is developed in proportion to the amount of gene-specific mRNA ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies